Moriyasu Yamauchi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Lymph Node Metastasis

Squamous Cell Carcinoma

Neoadjuvant Chemotherapy

Top Venues

International journal of molecular sciences

In vivo (Athens, Greece)

This page only lists publications with an associated author ORCID identifier.

Publications

Kanako Kawasaki, Keita Kai, Akimichi Minesaki, Sachiko Maeda, Moriyasu Yamauchi, Yuichiro Kuratomi
Chemoradiotherapy and Lymph Node Metastasis Affect Dendritic Cell Infiltration and Maturation in Regional Lymph Nodes of Laryngeal Cancer. International journal of molecular sciences 25 (4) (2024)
Mioko Matsuo, Muneyuki Masuda, Moriyasu Yamauchi, Kazuki Hashimoto, Ryunosuke Kogo, Masanobu Sato, Shogo Masuda, Takashi Nakagawa
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation. Cancers 16 (14) (2024)
Mioko Matsuo, Muneyuki Masuda, Moriyasu Yamauchi, Kazuki Hashimoto, Ryunosuke Kogo, Masanobu Sato, Shogo Masuda, Takashi Nakagawa
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation. Cancers 16 (14) (2024)
Kanako Kawasaki, Keita Kai, Akimichi Minesaki, Sachiko Maeda, Moriyasu Yamauchi, Yuichiro Kuratomi
Chemoradiotherapy and Lymph Node Metastasis Affect Dendritic Cell Infiltration and Maturation in Regional Lymph Nodes of Laryngeal Cancer. International journal of molecular sciences 25 (4) (2024)
Kanako Kawasaki, Keita Kai, Akimichi Minesaki, Sachiko Maeda, Moriyasu Yamauchi, Yuichiro Kuratomi
Chemoradiotherapy and Lymph Node Metastasis Affect Dendritic Cell Infiltration and Maturation in Regional Lymph Nodes of Laryngeal Cancer. International journal of molecular sciences 25 (4) (2024)
Mioko Matsuo, Muneyuki Masuda, Moriyasu Yamauchi, Kazuki Hashimoto, Ryunosuke Kogo, Masanobu Sato, Shogo Masuda, Takashi Nakagawa
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation. Cancers 16 (14) (2024)
Moriyasu Yamauchi, Akimichi Minesaki, Tomoya Ishida, Yuki Sato, Seiji Okamura, Hiroyuki Shuto, Nariyuki Tanaka, Eriko Hatayama, Natsuko Shibamiya, Yuichiro Kuratomi
Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma. In vivo (Athens, Greece) 37 (3) (2023)
Moriyasu Yamauchi, Akimichi Minesaki, Tomoya Ishida, Yuki Sato, Seiji Okamura, Hiroyuki Shuto, Nariyuki Tanaka, Eriko Hatayama, Natsuko Shibamiya, Yuichiro Kuratomi
Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma. In vivo (Athens, Greece) 37 (3) (2023)
Moriyasu Yamauchi, Akimichi Minesaki, Tomoya Ishida, Yuki Sato, Seiji Okamura, Hiroyuki Shuto, Nariyuki Tanaka, Eriko Hatayama, Natsuko Shibamiya, Yuichiro Kuratomi
Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma. In vivo (Athens, Greece) 37 (3) (2023)
Takahiro Wakasaki, Tomomi Manako, Ryuji Yasumatsu, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda, Moriyasu Yamauchi, Yuichiro Kuratomi, Emi Nishimura, Toranoshin Takeuchi, Mioko Matsuo, Rina Jiromaru, Kazuki Hashimoto, Noritaka Komune, Takashi Nakagawa
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study. PloS one 17 (7) (2022)